MDR1 Monoclonal Antibody
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bsm-34179m-100ul |
Product Name | MDR1 Monoclonal Antibody |
Applications | IHC |
Reactivity | Human |
Predicted Reactivity | Mouse |
Specifications | |
Conjugation | Unconjugated |
Host | Mouse |
Source | KLH conjugated synthetic peptide derived from human MDR1 |
Clonality | Monoclonal |
Clone # | 3C1 |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
Target | |
Gene ID | 5243 |
Swiss Prot | P08183 |
Subcellular location | Cell membrane |
Synonyms | ABC20; ABCB1; ATP binding cassette, sub family B (MDR/TAP), member 1; ATP-binding cassette sub-family B member 1; CD243; CLCS; Colchicin sensitivity; Doxorubicin resistance; GP170; MDR1; MDR1_HUMAN; Multidrug resistance 1; Multidrug resistance protein 1; P glycoprotein 1; P gp; P-glycoprotein 1; PGY1. |
Background | P Glycoprotein, the product of the MDR1 gene, is expressed in distinct non-malignant cells, typically cells with secretory and excretory functions. It is assumed to function as an ATP-dependent drug efflux pump with broad substrate specificity. The highest expression of P Glycoprotein has been observed in kidney (proximal tubules), liver (bile canaliculi), adrenal gland and intestine, suggesting that the primary role of P Glycoprotein is in the normal secretion of physiological metabolites and ingested chemicals into bile, urine and the lumen of the intestinal tract. Elevated levels of P Glycoprotein have also been reported in multidrug-resistant cell lines and in colon, endometrial, ovarian, and breast tumors, as well as in sarcomas and leukemias / lymphomas. |
Application Dilution | |
IHC | 1:100-500 |